Increased interleukin-18 content and angiogenic activity of sera from diabetic (Type 2) patients with background retinopathy.

Hyperglycaemia increases inflammatory cytokine concentration in the blood. Elevated levels of interleukin-18 (IL-18), a cytokine belonging to the interleukin-1 (IL-1) family, were recently reported in patients with Type 2 diabetes mellitus (DM2) and nephropathy. The aim of the present work was an examination of IL-18 concentration in the sera of elderly DM2 patients with nonproliferative retinopathy and age-matched control people and an estimation whether this cytokine plays pro- or anti-angiogenic role in in vivo angiogenic activity of their sera in mice cutaneous angiogenesis test. Recombinant human IL-18 injected intradermally to murine skin induced significant neovascular reaction. DM2 patients sera contained higher concentration of IL-18 and induced stronger neovascular reaction in mice skin than did the sera of corresponding control people. Sera from both groups of people after neutralization with antihuman IL-18 antibodies lost substantial part of their angiogenic activity.

[1]  R. Auerbach,et al.  Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the graft-vs.-host reaction , 1975, The Journal of experimental medicine.

[2]  B. de Geus,et al.  Transforming growth factor-beta and the glomerular extracellular matrix in renal pathology. , 1994, The Journal of laboratory and clinical medicine.

[3]  G. Trinchieri,et al.  Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. , 1998, The Journal of clinical investigation.

[4]  U. Demkow,et al.  Angiogenic activity and IL‐8 concentrations in peritoneal fluid and sera in endometriosis , 2002, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[5]  C. Tsalamandris,et al.  Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate: effects of angiotensin receptor blockade and sodium restriction. , 2002, Diabetes care.

[6]  E. Vlková,et al.  Polymorphism R25P in the gene encoding transforming growth factor-beta (TGF-beta1) is a newly identified risk factor for proliferative diabetic retinopathy. , 2002, American journal of medical genetics.

[7]  M. Kurimoto,et al.  Interleukin‐18 acts as an angiogenesis and tumor suppressor , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  Masafumi Koga,et al.  Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy. , 2003, Metabolism: clinical and experimental.

[9]  R. Merendino,et al.  Serum Levels of Interleukin-18 and sICAM-1 in Patients Affected by Breast Cancer: Preliminary Considerations , 2001, The International journal of biological markers.

[10]  R. Marfella,et al.  Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans: Role of Oxidative Stress , 2002, Circulation.

[11]  N. Horwood,et al.  Interleukin-18: perspectives on the newest interleukin. , 1998, Cytokine & growth factor reviews.

[12]  J. Forrester,et al.  Regulation of transforming growth factor-beta, basic fibroblast growth factor, and vascular endothelial cell growth factor mRNA in peripheral blood leukocytes in patients with diabetic retinopathy. , 1999, Metabolism: clinical and experimental.

[13]  A. Koch,et al.  Evidence of IL-18 as a Novel Angiogenic Mediator1 , 2001, The Journal of Immunology.

[14]  H. Mühl,et al.  Lack of Interferon-γ Production Despite the Presence of Interleukin-18 During Cutaneous Wound Healing , 2000, Molecular medicine.

[15]  R. A. Mahmoud,et al.  Increased serum levels of interleukin-18 in patients with diabetic nephropathy. , 2004, The Italian journal of biochemistry.

[16]  U. Demkow,et al.  Suppression of angiogenic activity of sera from diabetic patients with non-proliferative retinopathy by compounds of herbal origin and sulindac sulfone. , 2004, International journal of molecular medicine.

[17]  K. Sfiridaki,et al.  Interleukin-18 in multiple myeloma patients: serum levels in relation to response to treatment and survival. , 2004, Leukemia research.

[18]  S. Lee,et al.  TGF-betas synthesized by RPE cells have autocrine activity on mesenchymal transformation and cell proliferation. , 2001, Yonsei medical journal.